Pediatric Candidiasis Clinical Presentation

  • Author: Sabah Kalyoussef, DO; Chief Editor: Russell W Steele, MD   more...
 
Updated: Jul 22, 2011
 

History

Thrush

Infants with thrush may experience pain, poor feeding, or fussiness.

Cutaneous candidiasis

Patients with cutaneous candidiasis experience itching, burning, and soreness.

Most commonly affected areas are the diaper area in infants and toddlers and abdominal fat folds and groin in older individuals.

Paronychia and onychomycosis

Candidal paronychia and nail disease has a predilection for the fingernails.

Paronychia is usually painful.

Vulvovaginitis

Most women with vulvovaginitis complain of a creamy vaginal discharge with soreness and burning.

Dyspareunia is often present.

Otitis externa

Otitis externa is found most commonly in tropical and subtropical climates.

Malnutrition and immunosuppression are risk factors.

Candidiasis is clinically difficult to distinguish from other causes of otitis externa.

GI candidiasis

GI candidiasis is primarily observed in individuals who are immunocompromised, especially in persons with human immunodeficiency virus (HIV) infection and/or primary immunodeficiency.

This may be a cause of chronic diarrhea.

Common in infants, glossitis may occur in older children following use of broad-spectrum antibiotics or may signal immunodeficiency.

Esophagitis should be suspected in individuals who are immunocompromised when oral candidiasis is present. Symptoms include dysphagia and odynophagia. Risk of esophagitis is elevated in children taking H2 blockers.

Pneumonia

This is extremely rare and usually results from disseminated disease.

Cystitis

Risk factors for cystitis include indwelling urinary catheters, immunosuppression, diabetes mellitus, and use of broad-spectrum antibiotics.

Endophthalmitis

Endophthalmitis is the most common intraocular infection in newborns.

Risk factors include low birth weight and prolonged hospitalization.

CNS infections

CNS infections usually present as subacute meningitis.

Risk factors include indwelling catheters (especially shunts), prematurity, malnutrition, immunodeficiency, and organ transplantation.

Endocarditis

Risk factors for endocarditis include immunosuppression, HIV infection, intravenous catheters, corticosteroid use, prolonged hospitalization, and use of broad-spectrum antibiotics.

Hepatic (hepatosplenic) candidiasis

Risk factors include neutropenia.

Hepatic candidiasis may present with fever of unknown origin. It is usually a manifestation of disseminated candidiasis.

Hepatic candidiasis commonly occurs in oncology patients after a prolonged course of neutropenia. Symptoms develop with return of neutrophils.

Next

Physical

Thrush

White plaques are observed in the mouth and may affect the lips, tongue, gums, and palate (see the image below).

Typical appearance of thrush. Note multiple white Typical appearance of thrush. Note multiple white plaques on lips, gingivae, tongue, and palate.

Scraping of the lesions may reveal erythema and bleeding at the base (see following image). The plaques do not scrape off easily.

Cutaneous candidiasis

Lesions consist of beefy-red plaques, often with scalloped borders.

Satellite papules and pustules may be observed surrounding the plaques.

Maceration is often present, especially in intertriginous areas (see following image).

Candidal diaper dermatitis (see the image below) is generally confluent in intertriginous areas, whereas generic diaper dermatitis may demonstrate sparing in the folds.

Candidal diaper dermatitis. Note satellite papulesCandidal diaper dermatitis. Note satellite papules and involvement of intertriginous folds.

Paronychia and onychomycosis

Paronychia typically involves the cuticular fold of fingernails, causing redness, swelling, and pain.

Pus may be present.

Nail involvement usually stems from long-standing paronychia and causes a yellow discoloration of the nail, often with separation of the nail from the nail bed.

Genital candidiasis

With vulvovaginitis, a creamy white discharge is usually present. White plaques may be observed on an erythematous base of the vaginal mucosa or vulvar skin. Papules and pustules may be present.

With balanitis, lesions are usually observed on the glans penis and consist of erythematous plaques, pustules, or erosions.

GI disease

Glossitis is characterized by creamy or curdlike white plaques, which may be painful and bleed beneath when scraped.

With esophagitis, oral candidiasis may or may not be present. Weight loss is common.

Otitis externa

Tenderness of the pinna, aural discharge, and erythema characterize otitis externa.

Lymphadenopathy of postauricular or preauricular nodes may be present.

A grayish membrane may be present in the canal.

Hepatic candidiasis

This infection usually presents as abscesses in the liver and/or spleen.

Endocarditis

Endocarditis is characterized by fever and a new or changing heart murmur.

Symptoms relating to embolization to other organs (eg, CNS, kidneys, lungs, retina and choroid, skin) may be present.

Endophthalmitis

White well-circumscribed lesions of the retina and choroid in the posterior pole characterize endophthalmitis.

Isolation of candida from blood, urine, or other sources supports the diagnosis of endophthalmitis.

CNS infections

Signs consistent with meningitis are often present with CNS infections.

Evidence of candidal infection of other organ systems may be present.

Previous
Next

Causes

Candidal infections have differing presentations in patients who are immunocompetent versus persons who are immunocompromised.

Patient who is immunocompetent

Although candidal diaper rash is common in healthy infants, predisposing factors causing candidal infections in older individuals are often present.

The most common factor is the disruption of normal flora following a course of antibiotic therapy, which is most commonly observed as cutaneous candidiasis or vulvovaginitis.

Other risk factors for candidal infection relate to impaired immune function, including individuals with diabetes mellitus, premature infants, hosts who are immunocompromised, and persons using systemic or topical corticosteroids.

Other risk factors include obesity, heat, and excessive sweating.

Patient who is immunocompromised

Individuals who are immunocompromised are more susceptible to oral and cutaneous candidiasis and often have a more severe course.

Oral candidiasis may appear as acute or chronic atrophic candidiasis, which causes painful red erosions of the tongue and mucous membranes.

Candida species are frequent causes of central venous catheter infections.

Immunosuppression may also cause systemic candidiasis, which may present as fungemia or funguria. Candida species may cause fungal bezoars in the kidney or bladder, or candidiasis may cause abscesses in the liver or spleen. Candidal meningitis, arthritis, and endophthalmitis all have been reported.

Neonates

Neonates with very low birth weight are at a higher risk of developing candidemia.

Risk factors include low birth weight, broad spectrum antibiotic use, total parental nutrition, previous bloodstream infections, or necrotizing enterocolitis.

Chronic mucocutaneous candidiasis (CMCC)

CMCC is a cluster of disorders of cell-mediated immunity that presents as chronic severe candidal infections of the skin and mucous membranes.

Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Sabah Kalyoussef, DO  Fellow in Pediatric Infectious Diseases, Children's Hospital at Montefiore

Sabah Kalyoussef, DO is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Coauthor(s)

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Sanofi Pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

Michael E Greenberg, MD  MPH, Clinical Instructor, Department of Pediatrics, University of California at San Francisco

Michael E Greenberg, MD is a member of the following medical societies: Alpha Omega Alpha, Ambulatory Pediatric Association, American Academy of Pediatrics, and American Public Health Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Itzhak Brook, MD, MSc  Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Mark R Schleiss, MD  American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School

Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References

  1. Crislip MA, Edwards JE Jr. Candidiasis. Infect Dis Clin North Am. Mar 1989;3(1):103-33. [Medline].

  2. Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, et al. Risk Factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for Prevention. Clin Infect Dis. Jul 16 2010;[Medline].

  3. Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics. Apr 2007;119(4):772-84. [Medline].

  4. Kaufman D, Boyle R, Hazen KC. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of < 1000 grams birth weight. J Pediatr. Aug 2005;147(2):172-9. [Medline].

  5. Healy CM, Baker CJ, Zaccaria E. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. Aug 2005;147(2):166-71. [Medline].

  6. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics. Apr 2006;117(4):1243-52. [Medline].

  7. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. Mar 1 2009;48(5):503-35. [Medline]. [Full Text].

  8. Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics. Feb 2001;107(2):293-8. [Medline].

  9. Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J Pediatr. Aug 2005;147(2):135-41. [Medline].

  10. Manzoni P, Arisio R, Mostert M. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics. Jan 2006;117(1):e22-32. [Medline].

  11. [Best Evidence] Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. Jun 14 2007;356(24):2483-95. [Medline].

  12. Mondal RK, Singhi SC, Chakrabarti A, M J. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. Pediatr Crit Care Med. Nov 2004;5(6):561-5. [Medline].

  13. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr. Aug 2005;147(2):156-61. [Medline].

  14. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis. 2006;43:S15-27.

  15. Bacheller CD, Bernstein JM. Urinary tract infections. Med Clin North Am. May 1997;81(3):719-30. [Medline].

  16. Antifungal agents. In: Benitz WE, Tatro DS, eds. The Pediatric Drug Handbook. 3rd ed. St. Louis, Mo: Mosby; 1975.

  17. Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment. Pediatrics. Sep 27 2010;[Medline].

  18. Boiko S. Making rash decisions in the diaper area. Pediatr Ann. Jan 2000;29(1):50-6. [Medline].

  19. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 3rd ed. Baltimore, Md: Williams & Wilkins; 1990.

  20. Denning DW, Evans EG, Kibbler CC, et al. Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ. Nov 11 1995;311(7015):1277-81. [Medline].

  21. Dodds Ashley ES, Lewis R, Lewis JS. Pharmacology of sytemic antifungal agents. Clin Infect Dis. 2006;43:S28-39.

  22. du Vivier A, McKee PH, eds. Atlas of Clinical Dermatology. Philadelphia, Pa: WB Saunders; 1986.

  23. Elder ME. T-cell immunodeficiencies. Pediatr Clin North Am. Dec 2000;47(6):1253-74. [Medline].

  24. Elewski BE. Cutaneous mycoses in children. Br J Dermatol. Jun 1996;134 Suppl 46:7-11: discussion 37-8. [Medline].

  25. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. Jan 1999;12(1):80-96. [Medline].

  26. Harriet Lane Service, Children's Medical and Surgical Center, Johns Hopkins Hospital. Formulary. In: Siberry GK, Iannone R, eds. The Harriet Lane Handbook. 15th ed. St Louis, Mo: Mosby; 2000.

  27. Hay RJ. The management of superficial candidiasis. J Am Acad Dermatol. Jun 1999;40(6 Pt 2):S35-42. [Medline].

  28. Hoppe JE. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J. Sep 1997;16(9):885-94. [Medline].

  29. Kauffman CA. The changing landscape of invasive fungal infections: epidemiology, diagnosis, and pharmacologic options. Clin Infect Dis. 2006;43:S1-2.

  30. Kaufman DA. Aiming for zero: preventing invasive Candida infections in extremely preterm infants. NeoReviews. July, 2011;12(7):e381-e392.

  31. Kaufman DA. Challenging issues in neonatal candidiasis. Curr Med Res Opin. Jul 2010;26(7):1769-78. [Medline].

  32. Kaufman DA. Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates?. Adv Exp Med Biol. 2010;659:99-119. [Medline].

  33. Kaufman DA. Neonatal candidiasis: clinical manifestations, management, and prevention strategies. J Pediatr. Apr 2010;156 (Suppl 2):S53-S67.

  34. Legrand F, Lecuit M, Dupont B, Bellaton E, Huerre M, Rohrlich PS. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis. Mar 1 2008;46(5):696-702. [Medline].

  35. McClelland RS, Richardson BA, Hassan WM, Graham SM, Kiarie J, Baeten JM, et al. Prospective Study of Vaginal Bacterial Flora and Other Risk Factors for Vulvovaginal Candidiasis. J Infect Dis. Jun 15 2009;199(12):1883-1890. [Medline].

  36. Odio CM, Araya R, Pinto LE. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J. Dec 2004;23(12):1093-7. [Medline].

  37. Odom RB. Common superficial fungal infections in immunosuppressed patients. J Am Acad Dermatol. Sep 1994;31(3 Pt 2):S56-9. [Medline].

  38. Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 2006;43:S3-14.

  39. Schwarze R, Penk A, Pittrow L. Administration of fluconazole in children below 1 year of age. Mycoses. Apr 1999;42(1-2):3-16. [Medline].

  40. Singhi SC, Reddy TC, Chakrabarti A. Candidemia in a pediatric intensive care unit. Pediatr Crit Care Med. Jul 2004;5(4):369-74. [Medline].

  41. Smith PB, Morgan J, Benjamin JD, et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J. Mar 2007;26(3):197-200. [Medline].

  42. Smith PB, Steinbach WJ, Benjamin DK. Neonatal candidiasis. Infect Dis Clin North Am. Sep 2005;19(3):603-15. [Medline].

  43. Steinbach WJ. Antifungal agents in children. Pediatr Clin North Am. Jun 2005;52(3):895-915, viii. [Medline].

  44. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. Nov 16 1999;131(10):729-37. [Medline].

  45. Working Group of the British Society for Medical Mycology. Management of genital candidiasis. BMJ. May 13 1995;310(6989):1241-4. [Medline].

  46. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55(RR-11):1-94. [Medline].

  47. Zaoutis TE. Pediatric fungal infections: a conundrum in children. J Pediatr. 2010/04;156 (Suppl 2):S47-S52.

  48. Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis. May 1 2007;44(9):1187-93. [Medline].

  49. Zaoutis TE, Jafri HS, Huang LM, Locatelli F, Barzilai A, Ebell W. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics. Mar 2009;123(3):877-84. [Medline].

 
Previous
Next
 
Typical appearance of thrush. Note multiple white plaques on lips, gingivae, tongue, and palate.
Candidal diaper dermatitis. Note satellite papules and involvement of intertriginous folds.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.